Page last updated: 2024-08-24

tirofiban and Embolus

tirofiban has been researched along with Embolus in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's5 (71.43)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adina, Q; Bildirici, U; Celikyurt, U; Dervis, E; Ural, D; Yavuz, S1
Chiariello, M; D'andrea, C; Esposito, G; Piscione, F1
Chang, Y; Choi, CJ; Gimelli, G; Harding, S; Inglessis, I; Jang, IK; Walters, D; Wong, P1
Atmaca, Y; Erol, C; Ozdol, C1
Al-Mousa, EN; Arshad, MN; Campsey, M; Gandhi, R; Gibson, CM; Marble, SJ; Mattson, S; Mesley, R; Moynihan, JL; Murphy, S; Ryan, KA; Swanson, J1
Mohammad, SF; Solen, KA; Sukavaneshvar, S1
Henry, RG; Little, JW; McIntosh, BA; Miller, CS1

Reviews

2 review(s) available for tirofiban and Embolus

ArticleYear
Glycoprotein IIb/IIIa receptor inhibition in interventional cardiology.
    Journal of thrombosis and thrombolysis, 1999, Volume: 7, Issue:3

    Topics: Abciximab; Administration, Oral; Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Cardiology; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Embolism; Eptifibatide; Female; Fibrinolytic Agents; Follow-Up Studies; Forecasting; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Risk; Stents; Structure-Activity Relationship; Tirofiban; Treatment Outcome; Tyrosine

1999
Antithrombotic agents: implications in dentistry.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2002, Volume: 93, Issue:5

    Topics: Anticoagulants; Aspirin; Blood Coagulation Tests; Clopidogrel; Dental Care; Drug Interactions; Embolism; Fibrinolytic Agents; Hemostasis; Heparin; Heparin, Low-Molecular-Weight; Humans; Oral Hemorrhage; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Ticlopidine; Tirofiban; Tyrosine; Venous Thrombosis; Warfarin

2002

Trials

2 trial(s) available for tirofiban and Embolus

ArticleYear
The effect of glycoprotein IIb/IIIa receptor inhibitor on the microcirculation in patients undergoing high-risk coronary stenting; a prospective, randomized study.
    Journal of thrombosis and thrombolysis, 2003, Volume: 16, Issue:3

    Topics: Aged; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Embolism; Female; Humans; Male; Microcirculation; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Time Factors; Tirofiban; Tyrosine

2003
Glycoprotein IIb/IIIa receptor inhibition in interventional cardiology.
    Journal of thrombosis and thrombolysis, 1999, Volume: 7, Issue:3

    Topics: Abciximab; Administration, Oral; Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Cardiology; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Embolism; Eptifibatide; Female; Fibrinolytic Agents; Follow-Up Studies; Forecasting; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Risk; Stents; Structure-Activity Relationship; Tirofiban; Treatment Outcome; Tyrosine

1999

Other Studies

4 other study(ies) available for tirofiban and Embolus

ArticleYear
Early Thrombosuction and Tirofiban Use in Knee and Below-Knee Arterial Thrombosis.
    Medical science monitor : international medical journal of experimental and clinical research, 2017, Apr-30, Volume: 23

    Topics: Aged; Aged, 80 and over; Arteries; Embolism; Female; Hemorrhage; Humans; Knee Joint; Leg; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Thrombectomy; Thromboembolism; Tirofiban; Treatment Outcome; Tyrosine

2017
Tirofiban administration and percutaneous coronary intervention with stenting of saphenous vein graft thrombosis.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2009, Volume: 10, Issue:11

    Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Constriction, Pathologic; Coronary Angiography; Coronary Artery Bypass; Drug Administration Schedule; Embolism; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Male; Saphenous Vein; Stents; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine

2009
Coronary embolism in a patient with mitral valve prosthesis: successful management with tirofiban and half-dose tissue-type plasminogen activator.
    Chinese medical journal, 2007, Dec-20, Volume: 120, Issue:24

    Topics: Coronary Thrombosis; Embolism; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mitral Valve; Tirofiban; Tissue Plasminogen Activator; Tyrosine

2007
An in-vitro model to study device-induced thrombosis and embolism: evaluation of the efficacy of tirofiban, aspirin, and dipyridamole.
    Thrombosis and haemostasis, 2000, Volume: 83, Issue:2

    Topics: Animals; Anticoagulants; Aspirin; Blood Flow Velocity; Cattle; Dipyridamole; Dose-Response Relationship, Drug; Edetic Acid; Embolism; Equipment and Supplies; Equipment Design; Evaluation Studies as Topic; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Scattering, Radiation; Stents; Thrombosis; Tirofiban; Tyrosine

2000